Behavioral and Pharmacologic Treatment of Binge Eating and Obesity: Acute Treatment
Addictive Behaviors | Obesity & Weight Control
What is the purpose of this trial?
This study will test the effectiveness and relative efficacy of behavioral and pharmacologic treatments, alone and in combination, for the treatment of binge eating disorder (BED) in patients with obesity. This is an acute treatment comparing behavioral weight loss alone or in combination with naltrexone/bupropion medication.
- Ages18 years - 70 years
- Trial withNational Institute of Diabetes and Digestive & Kidney Diseases (NIDDK)
- Start Date02/27/2017
- End Date10/31/2023
- Last Updated07/15/2021
- Study HIC#1506016065